ReviewFrontiers in chemistry2026
Biogenic nanoparticles: overview of challenges in production, characterization and use.
Review in Frontiers in chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The biological synthesis of metal-based nanoparticles (NPs) is considered a sustainable and eco-friendly alternative to conventional chemical and physical approaches, offering improved biocompatibility and a reduced environmental footprint. The synthesis and advantages have been highlighted in many studies and reviews; however, the significant challenges continue to limit their broader adoption. This review focuses on these issues within the synthesis, characterization, applications and environment concerns. Limitations such as yield, lengthy and nonuniform synthesis, purification inefficiencies, and high variability between biological sources are discussed. Characterization remains problematic, as biomolecules as capping agents or biocoronas obscure accurate size, morphology, and surface chemistry assessments. Application-specific issues also persist, including instability, inconsistent reproducibility, and uncertainties in long-term safety and toxicity. Environmental risks represent a concern that has been mostly overlooked. These include the potential for bioaccumulation in living organisms, ecological toxicity that can disrupt entire ecosystems, and the current lack of adequate disposal frameworks for nanomaterials. Together, these issues underscore the urgent need for standardized and globally consistent regulatory oversight to ensure the safe development and application of nanotechnology. By critically evaluating challenges, this review aims to guide future research toward the development of robust, reproducible, and safe protocols that will enable the reliable integration of biogenic NPs into medicine, biotechnology, and environmental applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.